Today we are looking into CBD oil rather then pure hemp oil. What is CBD oil and why has its popularity soared over the last 5 years?
Its ever-growing recognition across Europe and the United States is making this supplement very difficult to ignore. Cannabidiol (CBD) is one of many Phyto-cannabinoids found in the hemp plant and is the non- psychoactive part, making up almost 40% of the plant. The CBD is extracted from the plant and then produced into a powder or more commonly an oil. The oil has been heralded with numerous health benefits which we will discuss today.
CBD oil and Depression and Anxiety.
Depression and anxiety affects a large percentage of the UK alone with reports suggesting between 1 in 4 people. CBD’s ability to interact with the serotonin and dopamine receptors in the brain and inducing a release of serotonin and dopamine through the body has received great evidence in how it really can aid with depression. Studies are also looking into how CBD can be used as an intervention for addictive behaviors especially for those coping with extreme anxiety.
CBD oil and sleep related conditions.
CBD is extremely effective at reducing anxiety and in doing so has been known to help increase sleep longevity and reduce the amount of insomnia. CBD has even been shown to reduce insomnia with people with chronic pain, drastically improving quality of life.
CBD oil and Pain relief
The human body is an amazing machine especially the way in which the body’s own Endocannabinoid system is involved in managing pain. CBD stops the body from absorbing Anandamide, a neurotransmitter associated with pain regulation in the body. Therefore, an increase in Anandamide in the blood stream may reduce the amount of pain someo
ne may suffer with. Due to its lack of intoxicating effects on the body and the lower potential for side effects this has become a very attractive alternative to other pain medications to those suffering with chronic pain
CBD oils use for long term illness
Out of all the associated benefits linked with CBD then this must be one of the most exciting for the future of the oil. You may have already seen all over social media how Cannabinoid reduces and stop seizures especially triggered by epilepsy , with studies showing how it can reduce seizures in the majority of those who had previously been non-responsive to medical drugs. Humans and pets alike! Studies are also showing how CBD can help for those with early Parkinson’s – We really are in exciting times for the growth and expansion of CBD oil.
As our attitudes change along with the expansion of the nation’s knowledge, we can only see great things for the future of this supplement. Here at Goodness Direct we will be expanding our range, but we are introducing this product with Bio Bloom, an organic plant grown to the highest standards for a high-quality CBD oil. This range comes with three strengths, 4%, 6% and 8% offering a comprensive range of CBD/CBDA concentrations so that you can find the right one to suit you the most.
Carlini, EA and JM Cunha. (1981). Hypnotic and antiepileptic effects of cannabidiol. Journal of clinical pharmacology, 21(8-9Suppl): 417S-427S. Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/7028792?dopt=Abstract
Chagas, MH et al. (2014). Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series. Journal of clinical pharmacy and therapeutics, 39(5): 564-6. Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/24845114
Cunha, JM et al. (1980). Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology, 21(3): 175-85. Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/7413719?dopt=Abstract
Crippa, JM (2011). Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. Journal of psychopharmacology, 25(1): 121-30. Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/20829306?dopt=Abstract
Guindon, J and AG Hohmann. (2009). The endocannabinoid system and pain. CNS & Neurological Disorders Drug Targets, 8(6): 403-21. Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/19839937
Hsiao, Y-T et al. (2012). Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rates. Neuropharmacology, 62(1): 373-384. Retrieved from: http://www.sciencedirect.com/science/article/pii/S0028390811003467
Kwon, Diana (2016, January 22). Can Cannabis Treat Epileptic Seizures? Scientific American. Retrieved from: https://www.scientificamerican.com/article/can-cannabis-treat-epileptic-seizures/
Massi, P. (2008). 5-Lipoxgenase and anadamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid. Journal of neurochemistry, 104(4): 1091-1100. Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/18028339
de Mello Schier, AR et al. (2014). Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa. CNS & Neurological Disorders Drug Targets, 13(6): 953-960. Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/24923339
Morgan, CJ et al. (2013). Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings. Addictive behaviors, 38(9): 2433-6. Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/23685330
Murillo-Rodriguez, E et al. (2014). Potential effects of cannabidiol as a wake-promoting agent. Current Neuropharmacology, 12(3): 269-272(4). Retrieved from: http://www.ingentaconnect.com/content/ben/cn/2014/00000012/00000003/art00006
Natural Medicines Therapeutic Research. Cannabidiol. (2017, April 3). Retrieved from: https://naturalmedicines.therapeuticresearch.com.
Prud’homme, M et al. (2015). Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence. Substance abuse, 9: 33-8. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444130/
Robson, PJ (2014). Therapeutic potential of cannabinoid medicines. Drug testing and analysis, 6(1-2): 24-30. Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/24006213
Russo, EB (2008). Cannabinoids in the management of difficult to treat pain. Therapeutics and clinical risk management, 4(1): 245-259. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503660/
Saito, VM et al. (2012). Cannabidiol modulation of neuroinflammatory disorders. Current neuropharmacology, 10(2): 159-66. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386505/
Zuardi, AW et al. (2006). Cannabidiol, a cannabis sativa constituent, as an antipsychotic drug. Brazilian journal of medical and biological research, 39(4): 421-9. Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/16612464?dopt=Abstract
Zuardi, AW (1953). Effects of ipsapirone and cannabidiol on human experimental anxiety. Journal of psychopharmacology, 7(1 Suppl): 82-8. Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/22290374?dopt=Abstract